Partially Pregelatinized Starch
Modified starch with balanced binding and disintegrating properties
Pharmaceutical Grade
USP/EP
Direct Compression
Modified starch with balanced binding and disintegrating properties
Partially pregelatinized starch is a modified starch where only a portion of the starch granules have been pregelatinized, providing a unique combination of binding and disintegrating properties.
Optimal balance of binding and disintegrating functions
Excellent for direct compression tablet manufacturing
Partially soluble in cold water for controlled release
Enhanced flow properties compared to native starch
Combines the binding properties of pregelatinized starch with the disintegrating properties of native starch in a single excipient.
Enhanced compaction properties compared to native starch, enabling better tablet hardness at lower compression forces.
Provides controlled disintegration time, allowing for optimized drug release profiles in tablet formulations.
| Appearance | White to off-white powder |
| Particle Size | ≤ 150 μm (90%) |
| Bulk Density | 0.50 - 0.70 g/cm³ |
| Tapped Density | 0.65 - 0.85 g/cm³ |
| Angle of Repose | ≤ 35° |
| Starch Content | ≥ 95% |
| Moisture Content | ≤ 10.0% |
| pH (10% slurry) | 5.0 - 7.0 |
| Ash Content | ≤ 2.0% |
| Pregelatinization Degree | 15 - 35% |
| Total Plate Count | ≤ 1000 CFU/g |
| Yeast & Mold | ≤ 100 CFU/g |
| E. coli | Absent/g |
| Salmonella | Absent/25g |
| S. aureus | Absent/g |
Ideal for direct compression tablet manufacturing, providing both binding and disintegrating properties.
Suitable for controlled release tablets where moderate disintegration is desired.
Filler and flow aid in hard gelatin capsule formulations with improved powder characteristics.
Component in multi-layer tablet formulations requiring different release characteristics.
Suitable for high-dose drug formulations where space-efficient excipients are needed.
Custom pharmaceutical formulations requiring specific binding and disintegration profiles.
Single excipient providing both binding and disintegrating functions, simplifying formulations.
Reduces the need for multiple excipients, lowering formulation costs.
Excellent flow and compaction properties improve manufacturing efficiency.
Approved by major pharmacopoeias for pharmaceutical use worldwide.
High-quality native starch is selected and tested for purity and functionality.
Partial pregelatinization is achieved through controlled heat and moisture treatment.
The product is dried and milled to achieve the desired particle size distribution.
Comprehensive testing ensures product meets all pharmaceutical specifications.
Contact our technical team for detailed specifications, samples, and custom solutions for your pharmaceutical formulations.